Bayer’s Monsanto Proposes $7.25 Billion Deal to Settle Roundup Cancer Claims

The proposed settlement is not an admission of wrongdoing, the company said.

A customer shops for Roundup weed killer in San Rafael, Calif., on July 9, 2018. Josh Edelson/AFP via Getty Images

German-based agrochemical company Bayer said on Feb. 17 that its Monsanto subsidiary has submitted a proposed $7.25 billion class‑action settlement over thousands of Roundup cancer lawsuits.

Bayer stated that it would implement a long-term claims program funded by capped annual payments for up to 21 years, “following court approval.” It will be submitted to the Circuit Court of the City of St. Louis.